Virus could help treat advanced cancers

June 12, 2018, University of Leeds
Virus could help treat advanced cancers
Human cancer cells in a culture. Credit: Matthew Daniels

Early results from a small-scale clinical trial have revealed the potential of a virus to treat some advanced cancers.

The findings, presented by scientists from the University of Leeds at the annual meeting of the American Society for Clinical Oncology, revealed that the specifically-engineered virus was able to infiltrate tumour cells, begin to destroy them and also to boost the body's immune system.

In one case the patient's tumour disappeared; in another, the tumour reduced in size.

The study looked at the effectiveness of the virus in treating eight patients with cancers that had spread: three were suffering from skin cancer or melanoma and five had bowel cancer which had spread to the liver.

Dr. Adel Samson from the Leeds Institute of Cancer and Pathology, who is one of the investigators, said: "The results so far are very promising. They show the virus was very effective in being able to switch on the body's immune system, allowing a patient's own defence systems to target the cancer.

"In addition, there was evidence that the virus itself was also destroying the ."

The study looked at the effectiveness of the virus as a neoadjuvant therapy, where it is used to try and shrink a tumour ahead of surgery.

The virus, called Pexa-Vec, was derived from the Vaccinia family of viruses and modified to target cancer cells. It was given to patients intravenously.

Two weeks after being given the virus, the patients had their tumours surgically removed.

Analysis of the cancerous tissue showed that the virus had been able to reach the site of the tumours and infiltrate the cancer cells. There were also signs that the cancer cells were beginning to die.

In one of the patients with bowel cancer that had spread to the liver, the tumour on the liver had been destroyed – in another of the bowel cancer patients, there had been partial destruction of the liver .

Dr. Samson said: "In two of the patients, we saw prior to administration of the virus that they had tumours that were growing.

"When the tumours were examined following surgery, the pathologist could identify dead cancer .

"Further research is needed to understand why the virus was so effective with these patients. We need to understand whether what we saw was the result of the virus destroying the , or was it the result of the virus enabling the immune system to be more effective – or was it a combination of the two?

"These initial findings are very exciting."

Virus could boost treatment options

The scientists believe the results open up the possibility that the virus could be given in combination with so-called 'checkpoint inhibitors' – drugs that can make the body's own defence system more potent.

The trial was run in partnership with Transgene, a French biotech company that holds the rights to investigate and commercially exploit the Pexa-Vec virus in Europe.

Dr. Maud Brandely, chief medical officer at Transgene, said: "The findings are beginning to show the potential of Pexa-Vec to help provide additional treatment options for patients with advanced cancer."

The effectiveness of Pexa-Vec is currently being tested in a larger phase-three clinical trial involving with liver . In that trial, doctors are trying to determine whether the is a more effective treatment than giving the conventional drug therapy.

Explore further: Genetically engineered virus kills liver cancer

Related Stories

Genetically engineered virus kills liver cancer

February 10, 2013
A genetically-engineered virus tested in 30 terminally-ill liver cancer patients significantly prolonged their lives, killing tumours and inhibiting the growth of new ones, scientists reported on Sunday.

Virus could treat brain tumours by boosting immune system

January 3, 2018
A virus injected directly into the bloodstream could be used to treat people with aggressive brain tumours, a major new study reports.

Fully reprogrammed virus offers new hope as cancer treatment

May 25, 2018
A cancer treatment that can completely destroy cancer cells without affecting healthy cells could soon be a possibility, thanks to research led by Cardiff University.

Link between HPV and cancer after kidney transplant

May 30, 2018
The European Cancer Stem Cell Research Institute at Cardiff University has shed light on the link between skin cancer development and kidney transplants, highlighting the importance for clinicians to monitor transplant patients ...

Antifungal drug eliminates sleeping bowel cancer cells in mice

May 31, 2018
An antifungal medication, commonly prescribed for toenail infections, could help eliminate dormant cells within bowel tumours, according to new research funded by Cancer Research UK and published in the Journal of Experimental ...

Lab-grown 'mini tumours' could personalise cancer treatment

February 23, 2018
Testing cancer drugs on miniature replicas of a patient's tumour could help doctors tailor treatment, according to new research.

Recommended for you

Student develops microfluidics device to help scientists identify early genetic markers of cancer

October 16, 2018
As anyone who has played "Where's Waldo" knows, searching for a single item in a landscape filled with a mélange of characters and objects can be a challenge. Chrissy O'Keefe, a Ph.D. student in the Department of Biomedical ...

Technique to 'listen' to a patient's brain during tumour surgery

October 16, 2018
Surgeons could soon eavesdrop on a patient's brain activity during surgery to remove their brain tumour, helping improve the accuracy of the operation and reduce the risk of impairing brain function.

Researchers elucidate roles of TP63 and SOX2 in squamous cell cancer progression

October 16, 2018
Squamous cell carcinomas (SCCs) are aggressive malignancies arising from the squamous epithelium of various organs, such as the esophagus, head and neck, lungs, and skin. Previous studies have demonstrated that two master ...

Function of neutrophils during tumor progression unraveled

October 15, 2018
Researchers at The Wistar Institute have characterized the function of neutrophils, a type of white blood cells, during early stages of tumor progression, showing that they migrate from the bone marrow to distant sites and ...

Delving where few others have gone, leukemia researchers open new path

October 15, 2018
A Wilmot Cancer Institute study uncovers how a single gene could be at fault in acute myeloid leukemia (AML), one of the deadliest cancers. The breakthrough gives researchers renewed hope that a gene-targeted therapy could ...

3-D mammography detected 34% more breast cancers in screening

October 15, 2018
In traditional mammography screening, all breast tissue is captured in a single image. Breast tomosynthesis, on the other hand, is three-dimensional and works according to the same principle as what is known as tomography. ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.